Specifications
- Purity
- ≥98% (HPLC)
- Appearance
- White to off-white powder
- Identity
- 1H-NMR
Properties
- Solvents
- ethanol (1mg/ml), methanol (1mg/ml), DMSO (10mg/ml), DMF (10mg/ml)
- Melting Point
- 101 - 102 °C
Category: Phytochemicals
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Magnolol is a bioactive compound isolated from the bark of M. officinalis that has been used in Asian traditional medicine for the treatment of anxiety, sleep disorders, and allergic diseases. Magnolol is an antifungal, antibacterial and antioxidant compound. It demonstrates anti-inflammatory activity by interferring with NF-?B signalling and NLRP3 inhibition. Magnolol can activate cannabinoid (CB) receptors, behaving as a partial agonist with selectivity for the peripheral CB2 subtype versus central CB1. It been identified as modulators of the GABAA receptors in vitro. It is a potent antitumor and antiangiogenic compound. Shown to inhibit HIF-1alpha/VEGF signalling, inhibiting invasion and metastasis through MMP2/MMP9 and inhibiting microtubule polymerization. Induces apoptosis through EGFR/PI3K/Akt pathway. Shows anti-diabetic/anti-obesity activity targeting nuclear receptors retinoic X receptor alpha (RXRalpha) and peroxisome proliferator activated receptor γ (PPARγ). In addition promotes thermogenesis.
Synonyms | 5,5'-Diallyl-2,2'-biphenyldiol, NSC 293099 |
---|---|
Purity | ≥98% (HPLC) |
Appearance | White to off-white powder |
CAS-Number | 528-43-8 |
Molecular Formula | C18H18O2 |
Molecular Weight | 266.33 |
Identity | 1H-NMR |
Solvents | ethanol (1mg/ml), methanol (1mg/ml), DMSO (10mg/ml), DMF (10mg/ml) |
Melting Point | 101 – 102 °C |
Smiles | OC1=CC=C(CC=C)C=C1C2=CC(CC=C)=CC=C2O |
InChi Key | VVOAZFWZEDHOOU-UHFFFAOYSA-N |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice | Protect from light and moisture. |
Use / Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Hazard statements | H315-H318-H335-H411 |
Precautionary statements | P261-P273-P280-P305 + P351 + P338 |
GHS Symbol | GHS05+GHS07+GHS09 |
Signal word | Danger |
RIDADR | UN 3077 9 |
Transportation | Packing Group III |
References | (1) K. Watanabe, et al., Planta Med. 49, 103 (1983), (2) J.P. Wang, et al., Naunyn Schmiedebergs Arch. Pharmacol. 346, 707 (1992), (3) Y. Maruyama, et al., J. Nat. Prod. 61, 135 (1998), (4) K.H. Bang, et al., Arch. Pharm. Res. 23, 46 (2000), (5) K.Y. Ho, et al., Phytother. Res. 15, 139 (2001), (6) J. Ai, et al., Pharmacology 63, 34 (2001), (7) K. Ikeda & H. Nagase, Biol. Pharm. Bull. 25, 1546 (2002), (8) K. Ikeda, et al., Phytother. Res. 17, 933 (2003), (9) J. Park, et al., Eur. J. Pharmacol. 496, 189 (2004), (10) A.K. Tse, et al., Mol. Immunol. 44, 2647 (2007), (11) D.H. Lee, et al., J. Cell Biochem. 106, 1113 (2009), (12) E.S. Hwang & K.K. Park, Biosci. Biotechnol. Biochem. 74, 961 (2010), (13) H. Zhang, et al., PLoS One 6, e28253 (2011), (14) V. Rempel, et al., ACS Med. Chem. Lett. 4, 41 (2013), (15) M.C. Chen, et al., Biochem. Pharmacol. 85, 1278 (2013), (16) Y. Sakaue, et al., Microbiol. Immunol. 60, 10 (2016), (17) J. Shen, et al., Cell Physiol. Biochem. 42, 1789 (2017), (18) F. Huang, et al., Mol. Med. Rep. 16, 4817 (2017), (19) H.A. Parray, et al., Nutrition 50, 82 (2018) |
Quantity | 10 mg, Bulk |